Archive: 29/08/2019

Lower risk for heart failure with new type 2 diabetes drug

The new drug type for type 2 diabetes, SGLT2 inhibitors, are associated with a reduced risk of heart failure and death, as well as of major cardiovascular events, a major Scandinavian registry study led from Karolinska Institutet ...

page 5 from 9